Unlike other weight-loss injections, retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously, whereas typical injections target one or two of these receptors
Interaction terms with variables considered in subgroups analysis were also examined
I also suggest the following approach to treating DED in patients taking GLP-1s: Long-term management I always let patients know that by taking a positive approach to preventive self-care by controlling their A1C, losing weight, and following a healthier diet with a GLP-1, theyre also helping their eyes
Peeters F, Cassiman C, Van Keer K, Levtchenko E, Veys K, Casteels I (2019) Ophthalmic outcome in a Belgian cohort of cystinosis patients treated with a compounded preparation of cysteamine eye drops: retrospective analysis
That is nearly two-thirds of participants experiencing some degree of benefit